Showing results (151-160 of 2,364) with videos related to
Sort By:
Pageof 237
British Journal of Clinical Pharmacology|July 1, 1990
Is cyclosporin A an inhibitor of drug metabolism?G Li, G Treiber, J Meinshausen, et al.British Journal of Clinical Pharmacology|December 2, 1998
Stereoselective steady state disposition and action of propafenone in Chinese subjectsG Li, P L Gong, J Qiu, et al.The Journal of Pharmacology and Experimental Therapeutics|June 1, 1990
Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug actionG Mikus, M Eichelbaum, C Fischer, et al.Clinical Pharmacokinetics|August 1, 1993
Pharmacokinetics of epoetin (recombinant human erythropoietin) after long term therapy in patients undergoing haemodialysis and haemofiltrationU Gladziwa, U Klotz, K Bäumer, et al.Deutsche Medizinische Wochenschrift (1946)|March 8, 1985
[Successful acute treatment of chronic inflammatory intestinal diseases with oral 5-aminosalicylic acid]K Maier, P Frühmorgen, J C Bode, et al.British Journal of Clinical Pharmacology|September 1, 1988
Pharmacokinetics and dynamics of famotidine in patients with renal failureU Gladziwa, U Klotz, D R Krishna, et al.Digestive Diseases and Sciences|January 1, 1994
Superoxide inhibition following different stimuli of respiratory burst and metabolism of aminosalicylates in neutrophilsH Allgayer, S Rang, U Klotz, et al.European Journal of Clinical Pharmacology|January 1, 1993
Pharmacokinetics and pharmacodynamics of famotidine in patients with reflux oesophagitisU Gladziwa, S Wagner, K V Dakshinamurty, et al.British Journal of Clinical Pharmacology|March 28, 1998
Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme inductionM F Fromm, K Dilger, D Busse, et al.Der Internist|December 23, 2003
[Drug interactions. Mechanisms and clinical relevance]U Klotz, W Beil, C Gleiter, et al.Pageof 237